We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
- Authors
Duchayne, Eliane; Fenneteau, Odile; Pages, Marie-Pierre; Sainty, Danielle; Arnoulet, Christine; Dastugue, Nicole; Garand, Richard; Flandrin, Georges; Groupe Français d'Hématologie Cellulaire; Groupe Français de Cytogénétique Hématologique
- Abstract
Since the WHO classification of haematological malignancies recommended the description of global entities, we performed a national M7-AML study to correlate morphological, immunological and cytogenetic features, and to find new clinically relevant M7 entities. This study is based on accurate morphological and immunological study to select pure megakaryoblastic proliferations and to eliminate megakaryocytic participation in haemopathies. We collected 53 cases: 23 adults and 30 children. We confirm the wide heterogeneity of adult M7. In adults, the cytogenetic abnormalities are frequently those of secondary leukaemia while a few patients have a previous history and morphological features of dyshaematopoiesis; their outcome is very poor. Among children, besides the well-known Down syndrome M7, we in particular, studied ten t(1;22) M7 and one OTT-MAL transcript positive case with normal karyotype presenting specific features. We were already aware of their younger age, female and tumoral presentation, but we also found a lower percentage of bone marrow blasts, sometimes without any megakaryoblastic bone marrow involvement, but always, with a dysmegakaryocytopoiesis associated with micromegakaryocytes. They are generally good responders to intensive AML chemotherapy with very long disease-free survivals (DFS). Accordingly, OTT-MAL transcript study, in infant M7 with normal karyotype, is recommended and we feel that this entity should be added to the WHO AML classification.
- Publication
Leukemia & lymphoma, 2003, Vol 44, Issue 1, p49
- ISSN
1042-8194
- Publication type
Journal Article
- DOI
10.1080/1042819021000040279